September 22, 2015
In Re Namenda Direct Purchaser Antitrust Litigation
Case Number:
1:15-cv-07488
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Baker & Hostetler
- Berger Montague
- Buchanan Ingersoll
- Faruqi & Faruqi
- Fenwick & West
- Garwin Gerstein
- Goodwin Procter
- Heim Payne
- Odom & Des Roches
- Quinn Emanuel
- Smith Segura
- White & Case
- Wilkinson Stekloff
Companies
- Allergan PLC
- Cardinal Health Inc.
- Dr. Reddy's Laboratories Ltd.
- Forest Laboratories Inc.
- Humana Inc.
- J.M. Smith Corp.
- Macleods Pharmaceuticals Ltd.
- Merz Pharma GmbH & Co KGaA
- Rochester Drug Cooperative Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 15, 2020
$88M Cut From Requested $157.5M Atty Fee In Namenda Deal
A Manhattan federal judge on Monday slashed nearly $88 million from a $157.5 million fee award requested by Garwin Gerstein & Fisher LLP and five other firms for guiding wholesalers of the Alzheimer's drug Namenda to a $750 million antitrust settlement with a unit of Allergan PLC.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login